USA Compression Partners will move its common-unit listing from the NYSE to the TXSE, with NYSE trading ending October 2, 2026, and TXSE trading beginning October 5, 2026. The USAC ticker stays unchanged, and unitholders need no action for the transfer.
Key Highlights
- USA Compression Partners approved the voluntary listing Withdrawal on September 3, 2026.
- USAC will remain the ticker after trading moves to the TXSE.
- Unitholders are not required to take action for the exchange transfer.
NYSE Exit and TXSE Start Dates
The change moves the listing venue for the partnership’s common units. Approval for the voluntary withdrawal from the NYSE was given on September 3, 2026. USA Compression Partners (NYSE: USAC) issued a related press release on September 10, 2026. The common units representing limited partner interests will continue under the USAC ticker after the exchange change. Unitholders do not need to take action in connection with the transfer.
Texas Platform and Unitholder Impact
USA Compression said the move aligns its Texas-based legacy with the TXSE’s technology-driven platform. The Partnership said the transfer creates opportunities to enhance value and support its continued growth.
FAQs
Q: What happens to USAC’s NYSE listing?
A: Trading of USA Compression Partners’ common units on the New York Stock Exchange is expected to end at market close on October 2, 2026. Trading is expected to begin on the TXSE at market open on October 5, 2026.
Q: Do USA Compression Partners unitholders need to take action?
A: No. USA Compression Partners said unitholders do not need to take action in connection with the listing transfer, and the USAC ticker will remain unchanged.
Q: Will the ticker symbol change when trading moves to the TXSE?
A: No. The common units will trade on the Texas Stock Exchange under the existing USAC ticker symbol after the listing transfer becomes effective.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.